- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: [14C]-TAK-385 Oral Solution
Total 1745 results
-
People's Hospital of Zhengzhou UniversityCompletedAn Individualized Administration Research of Voriconazole Based on CYP2C19 Gene Polymorphism and TDMInvasive Fungal InfectionChina
-
Lydia KwakSwedish Council for Working Life and Social ResearchCompletedStress | Mental DisorderSweden
-
AstraZenecaCompletedPharmacokineticsUnited States
-
The Faculty Hospital Na BulovceCompletedSmall Bowel Obstruction | Acute Appendicitis | Perforated Gastroduodenal UlcerCzech Republic
-
Rawalpindi Medical CollegeCompleted
-
Modulation Therapeutics, Inc.H. Lee Moffitt Cancer Center and Research InstituteRecruitingUveal Melanoma | MetastaticUnited States
-
Peking University Third HospitalRecruiting
-
Seagen Inc.Millennium Pharmaceuticals, Inc.CompletedNeoplasms | Lymphoma, Non-Hodgkin | Lymphoma, Large-Cell, Anaplastic | Disease, Hodgkin | CarcinomasUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Modern Biosciences LtdRecruitingPharmacokineticsUnited Kingdom
-
Markus MaparaITB-Med LLCRecruiting
-
University of California, San FranciscoNational Cancer Institute (NCI)TerminatedProstate AdenocarcinomaUnited States
-
Radboud University Medical CenterGlaxoSmithKlineCompletedHIV Infection | Fungal InfectionNetherlands
-
AstraZenecaCompletedHealthy SubjectsUnited Kingdom
-
Yeditepe UniversityCompletedLocal Anesthesia | Cannula Site PainTurkey
-
H. Lee Moffitt Cancer Center and Research InstituteNational Cancer Institute (NCI)CompletedIntraocular Melanoma | Melanoma (Skin)United States
-
Millennium Pharmaceuticals, Inc.Completed
-
Jonsson Comprehensive Cancer CenterJanssen Inc.Active, not recruitingRecurrent Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma | Prostate Adenocarcinoma With Focal Neuroendocrine DifferentiationUnited States
-
Vertex Pharmaceuticals IncorporatedRecruiting
-
Daiichi Sankyo Co., Ltd.AstraZenecaCompletedNeoplasm MetastasisKorea, Republic of, Taiwan, Japan
-
Vertex Pharmaceuticals IncorporatedCompleted
-
SanofiCompletedType 2 DiabetesUnited States, Canada, Chile, Czech Republic, Estonia, France, Germany, Hungary, Italy, Latvia, Lithuania, Mexico, Poland, Romania, Russian Federation, Spain, Ukraine, United Kingdom
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityUnknown
-
National Cancer Institute (NCI)WithdrawnRecurrent Classic Hodgkin Lymphoma | Refractory Classic Hodgkin Lymphoma
-
Sanofi Pasteur, a Sanofi CompanyCompletedHealthy Volunteers (Meningococcal Infection)United States, Puerto Rico
-
Aravind Eye Care SystemUnknownMycotic Corneal UlcerIndia
-
Pierre Fabre Dermo CosmetiqueQuanta MedicalUnknown
-
Cidara Therapeutics Inc.RecruitingMycoses | Candidemia | Fungemia | Fungal Infection | Invasive Candidiasis | Invasive Fungal Disease | Pneumocystis | Mold Infection | Prophylaxis of Invasive Fungal Infections | AspergillusUnited States, Germany, France, Belgium, Canada, Italy, Spain, United Kingdom, Turkey, Switzerland
-
University of PecsEnrolling by invitation
-
Alexion PharmaceuticalsCelerion; Achillion, a wholly owned subsidiary of AlexionCompleted
-
Roswell Park Cancer InstituteCelldex TherapeuticsCompletedAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Refractory Anemia | Blasts 30 Percent or Less of Bone Marrow Nucleated CellsUnited States
-
CelgeneNot yet recruiting
-
Jazz PharmaceuticalsCompletedEvaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4 | Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19...United Kingdom
-
Vertex Pharmaceuticals IncorporatedNot yet recruiting
-
Jennifer Holder-MurrayBerry ConsultantsRecruitingPerioperative OptimizationUnited States
-
SanofiTerminatedT-cell Type Acute Leukemia-Precursor | T-lymphoblastic Lymphoma/LeukaemiaHungary, United States, Finland, France, Italy, Lithuania, Russian Federation
-
Millennium Pharmaceuticals, Inc.CompletedLymphoma | Nonhematologic MalignanciesUnited States
-
Henan University of Traditional Chinese MedicinePeking University First Hospital; Chengdu University of Traditional Chinese... and other collaboratorsUnknownHenoch-Schönlein Purpura NephritisChina
-
Massachusetts Eye and Ear InfirmaryRecruiting
-
Federico II UniversityRecruitingBurning Mouth SyndromeItaly
-
Aeovian Pharmaceuticals, Inc.RecruitingHealthy ParticipantsAustralia
-
Cerevel Therapeutics, LLCCompleted
-
Sunshine Lake Pharma Co., Ltd.Active, not recruiting
-
Agios Pharmaceuticals, Inc.Completed
-
Bristol-Myers SquibbCompletedMalignancies MultipleUnited States
-
University Hospital Schleswig-HolsteinCompletedLeukemiaSwitzerland, Germany, Austria
-
PfizerCompletedFungal InfectionNetherlands
-
Mayo ClinicNational Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Prostate Carcinoma | Recurrent Prostate Carcinoma | Stage III Prostate Cancer | Stage IV Prostate CancerUnited States
-
KBP BiosciencesCovanceCompletedHealthy | Drug Drug InteractionUnited States
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States